Alentemol (INN) (developmental code name U-66444B), or alentamol, is a selective dopamine autoreceptor agonist described as an antipsychotic, which was never marketed.[1][2]

References

  1. ^ William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 143–. ISBN 978-0-8155-1856-3.
  2. ^ A.F. Casy (11 November 2013). The Steric Factor in Medicinal Chemistry: Dissymmetric Probes of Pharmacological Receptors. Springer Science & Business Media. pp. 178–. ISBN 978-1-4899-2397-4.


Allikas: https://en.wikipedia.org/wiki/Alentemol
No tags for this post.